Abstract Context The European Association of Urology (EAU) has released an updated
version of the guidelines on non–muscle-invasive bladder cancer (NMIBC). Objective To …

Context This overview presents the updated European Association of Urology (EAU)
guidelines for non–muscle-invasive bladder cancer (NMIBC), TaT1, and carcinoma in situ …

Bladder cancer is a highly prevalent disease and is associated with substantial morbidity,
mortality and cost. Environmental or occupational exposures to carcinogens, especially …

Abstract The Tumor-Node-Metastasis (TNM) classification on cancer staging, jointly
developed by the American Joint Commission on Cancer (AJCC) and the Union for …

Abstract Context The European Association of Urology (EAU) panel on Non–muscle-
invasive Bladder Cancer (NMIBC) released an updated version of the guidelines on Non …

Purpose: Although associated with an overall favorable survival rate, the heterogeneity of
non-muscle invasive bladder cancer (NMIBC) affects patients' rates of recurrence and …

Context Initial treatment for most bladder cancers (BCs) involves transurethral resection
(TUR) or tumours. Often more cancer is found after the initial treatment in around half of …

Non‐muscle‐invasive bladder cancer (NMIBC) represents the vast majority of bladder
cancer diagnoses, but this definition represents a spectrum of disease with a variable …

Objectives CG0070 is a replication-competent oncolytic adenovirus that targets bladder
tumor cells through their defective retinoblastoma pathway. Prior reports of intravesical …

CONTEXT: Some studies report that tumour progression in patients with non–muscle-
invasive bladder cancer (NMIBC) is associated with a poor prognosis. However, no …